UCB’s cover photo
UCB

UCB

Pharmaceutical Manufacturing

Inspired by patients. Driven by science.

About us

UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With more than 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2024 Key Financials: € 6.15 billion global revenue Specialties: Neurology, Immunology

Industry
Pharmaceutical Manufacturing
Company size
5,001-10,000 employees
Headquarters
Brussels
Type
Privately Held
Founded
1928
Specialties
Neurology, Immunology, and Healthcare Innovation Beyond Medicine

Locations

Employees at UCB

Updates

  • View organization page for UCB

    288,479 followers

    Confidential data silos are one of the biggest obstacles to collaboration in science and innovation. Enter FLuID, a novel approach that allows pharmaceutical companies to securely share critical insights without exposing sensitive data. Now published in Nature Machine Intelligence, this research showcases a privacy-first framework for groundbreaking collaboration. Explore this visionary work and its potential to transform not only drug discovery but countless other industries. You can read more here https://lnkd.in/eZ-J4WMf

    • No alternative text description for this image
  • View organization page for UCB

    288,479 followers

    Revolutionizing collaboration without compromising privacy - that’s the promise of FLuID (Federated Learning Using Information Distillation). Recently published in Nature Machine Intelligence, this new methodology aims to transform how pharmaceutical companies share insights to build better predictive models while keeping their data private. Curious about how FLuID works and its application in drug discovery? Read more here https://lnkd.in/eZ-J4WMf

  • View organization page for UCB

    288,479 followers

    We are proud to share the incredible recognition received by The Unbearable Home campaign at the recent PM Society Awards, where it earned five awards, including the prestigious Best in Show! 🏆  🏅 Gold for Best Disease Awareness Campaign for HCPs  🏅 Gold for Best Use of Insights  🏅 Gold for Best Design Craft  🥈 Silver for Meetings and Exhibitions  ✨ Best in Show Award Rooted in the lived experiences of real patients, this campaign was designed to make HS (hidradenitis suppurativa) more visible to healthcare professionals. By combining patient insights with bold, creative storytelling, it shined a light on the physical and emotional challenges faced by those impacted by HS. Judges praised its ability to create a genuine emotional connection with its audience, motivating dermatologists to take action and strive for better patient outcomes. The Unbearable Home reflects our broader commitment to improving understanding, care, and outcomes in HS. This recognition strengthens our resolve to continue working alongside the HS community to drive meaningful progress and amplify the voices of those living with this condition. If you’d like to explore more about The PM Society Awards, find out more here: https://lnkd.in/eyGPPZSE #PharmaMarketing #HSawareness #DrivingProgress #AwardWinningCampaign Chiara Danelli

    • No alternative text description for this image
  • View organization page for UCB

    288,479 followers

    On #WORDDAY2025, we join the global effort to raise awareness about rheumatic diseases in children and young people. Too often, conditions such as rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis are misunderstood or overlooked, delaying the critical care young patients need. At UCB, we are dedicated to advancing the standard of care in rheumatic diseases. We believe that early diagnosis and timely referrals to specialists can transform lives—not just for children and adolescents affected, but for their families, too. To make this a reality, we must work together to increase understanding. Parents, doctors, teachers, and the public all play a role in recognizing symptoms and ensuring no child or young person faces this challenge alone. Together, we can build a future of hope and improved outcomes. Let’s spread the word and make a difference.  #WORDDAY2025 #RheumaticDiseases #ElevatingCare Learn more: https://lnkd.in/eGvEgndy

    • No alternative text description for this image
  • View organization page for UCB

    288,479 followers

    When talent meets purpose, extraordinary things happen. We're cultivating a workplace where every voice matters and every perspective is valued. Together, we're building careers with meaning while making a lasting difference to people living with severe diseases.  Discover a future where professional growth and patient impact go hand in hand. #MakeYourMarkForPatients #TeamUCB #PharmaJobs Learn more at UCB Careers https://lnkd.in/dHkyid5y

    • No alternative text description for this image
  • View organization page for UCB

    288,479 followers

    To bridge the gap between medical professionals and those living with chronic conditions, we must learn from their experiences. By listening to different perspectives to inform our research, we can work to transform groundbreaking science into life-changing treatments. 🗣️ We caught up with UCB colleagues at congresses earlier this year to explore how these partnerships lead to better outcomes. #UCB #Patients

  • View organization page for UCB

    288,479 followers

    Today, on #IWD2025, UCB stands with women around the world to #AccelerateAction to emphasise the importance of taking steps towards greater representation of women in clinical trials.   Read more from Marie Teil today!

    View profile for Marie Teil

    Pharmaceutical Executive with 20+ years of experience | Global Head, Women of Childbearing Age Program @ UCB | Dedicated to advancing science in women's health.

    As we gear up to celebrate International Women’s Day 2025, I’m proud and inspired by the progress UCB is making to support this year’s theme, #AccelerateAction. Our commitment to including women of childbearing age in clinical trials is a crucial step toward ensuring that every woman has access to the best possible care. Learn more: http://bit.ly/4iuHSd4 How will you help #AccelerateAction today? Let me know in the comments! #IWD2025 #TeamUCB

    • No alternative text description for this image

Similar pages

Funding

UCB 3 total rounds

Last Round

Post IPO equity

US$ 101.0M

See more info on crunchbase